| Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
|---|
| 01/06/2005 | US20050003482 Expression vector comprising nucleotide sequences coding foot and mouth viral, as well as, immunoglobulin sequences for use in generation imunotherapeutics |
| 01/06/2005 | US20050003457 Immunoglobulin which binds osteoclastogenesis inhibitory factor binding molecules (OBM)) and prevents bone resorption for use in treatment and prevention of bone disorders |
| 01/06/2005 | US20050003406 Using expression pattern of notch signaling pathway protein (JAG2) as diagnostic indicator of cell proliferative disorders |
| 01/06/2005 | US20050003403 Multimeric protien for use in treatment and prevention of infections, nervous system, inflammatory, autoimmune and cell proliferative disorders |
| 01/06/2005 | US20050003347 Protein fusion comprised of heavy chain with variable region, constant region, multivalent binding surface comprised of two conventional antigen binding sites and at least one non-conventional binding site formed by an interface between adjacently positioned heavy chain variable regions |
| 01/06/2005 | US20050002922 Side effect free treatment of neuropsychiatric, neurological and behavioral disorders; anxiety; easy to administer; kits |
| 01/06/2005 | US20050000457 Method for the development of ruminant feed formulations |
| 01/06/2005 | CA2771875A1 Variant humicola grisea cbh1.1 |
| 01/06/2005 | CA2530248A1 Modified vectors for organelle transfection |
| 01/06/2005 | CA2528961A1 Methods of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular antagonist |
| 01/06/2005 | CA2528597A1 Stabilized immunomodulatory oligonucleotides |
| 01/06/2005 | CA2528544A1 Compositions and methods for regulating polysaccharides of a plant cell |
| 01/06/2005 | CA2528536A1 Transcription factors |
| 01/06/2005 | CA2528077A1 Methods for predicting the course of a malignant disease |
| 01/06/2005 | CA2527958A1 Methods and compositions for enhancing the efficacy and specificity of rnai |
| 01/06/2005 | CA2527689A1 Recombinant anti-cd30 antibodies and uses thereof |
| 01/06/2005 | CA2527022A1 Fine mapping of chromosome 17 quantitative trait loci and use of same for marker assisted selection |
| 01/06/2005 | CA2526639A1 Chimeric rnas and their use for cancer diagonostics and therapy |
| 01/06/2005 | CA2526122A1 Compositions for down-regulation of ccr5 expression and methods of use therefor |
| 01/06/2005 | CA2525333A1 Trichoderma genes |
| 01/06/2005 | CA2521662A1 Methods and compositions for enhancing immune response |
| 01/04/2005 | US6838447 Immobilized nucleotide chargable particles |
| 12/30/2004 | US20040268444 Introducing exogenous genes into apical meristematic cells of embryonic axis of leguminous plants by bombarding plant cells with DNA construct for conferring herbicide resistance, inducing multiple shoot formation via culturing with cytokinin, then selecting shoots; soybeans, beans, cowpea and peanuts |
| 12/30/2004 | US20040268443 Transgenic expression of a phytochrome a gene |
| 12/30/2004 | US20040266761 thromboembolic disorder treatment; anticoagulant agents |
| 12/30/2004 | US20040266706 Cross-linked oligomeric compounds and their use in gene modulation |
| 12/30/2004 | US20040265955 Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof |
| 12/30/2004 | US20040265952 protein containing a modified amino acid that carries an azido or alkynyl group for conjugation to a second molecule such as polymer, label or drug that carries an alkynyl or azido group; translation biochemistry in eukaryotic cells; gene expression inhibitors |
| 12/30/2004 | US20040265915 Detecting (via fluorescent microscopy, fractionation) fusion protein expression/aggregation after contacting cell containing signal transduction pathway with immunoglobulins and/or antigen presenting cell expressing major histomcompatability complex; high throughput assay |
| 12/30/2004 | US20040265889 biomarker polypeptides for determining if a test substance will cause hepatotoxicity; kits |
| 12/30/2004 | US20040265867 the Riley-Day syndrome; localization will permit prenatal diagnosis in affected families |
| 12/30/2004 | US20040265861 Materials and methods for identifying genes and/or agents that alter replicative lifespan |
| 12/29/2004 | WO2004113506A2 A method for the development of ruminant feed formulations |
| 12/29/2004 | WO2004113505A2 System and method for sequence distance measure for phylogenetic tree construction |
| 12/29/2004 | WO2004113503A2 Mbms as modifiers of branching morphogenesis and methods of use |
| 12/29/2004 | WO2004113502A2 Identification of therapeutic agents using genetic fingerprinting |
| 12/29/2004 | WO2004113501A2 Methods and compositions relating to lipid accumulation |
| 12/29/2004 | WO2004113500A2 B7s1: an immune modulator |
| 12/29/2004 | WO2004113499A2 Modulation of flowering time by the pft1 locus |
| 12/29/2004 | WO2004113498A2 Rna interferases and methods of use thereof |
| 12/29/2004 | WO2004113497A2 Gene delivery to tumors |
| 12/29/2004 | WO2004113496A2 Double stranded compositions comprising a 3’-endo modified strand for use in gene modulation |
| 12/29/2004 | WO2004113495A2 Rna-based transcriptional regulators |
| 12/29/2004 | WO2004113494A2 Methods for producing preparations of recombinant aav virions substantially free of empty capsids |
| 12/29/2004 | WO2004113493A2 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site |
| 12/29/2004 | WO2004101767A3 Cbi analogues of the duocarmycins and cc-1065 |
| 12/29/2004 | WO2004096999A3 In vitro translation system |
| 12/29/2004 | WO2004078926A3 Immunologigal markers |
| 12/29/2004 | WO2004072244A3 Polymerase-based protocols for generating chimeric oligonucleotides |
| 12/29/2004 | WO2004065565A3 Identification and use of informative sequences |
| 12/29/2004 | WO2004065542A3 MAT2As AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 12/29/2004 | WO2004042004A3 Mouse model for autoimmune disorders |
| 12/29/2004 | WO2004037996A3 Evaluation of breast cancer states and outcomes using gene expression profiles |
| 12/29/2004 | WO2004015072A3 Mrbs as modifiers of the rb pathway and methods of use |
| 12/29/2004 | EP1491093A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 12/29/2004 | EP1490511A2 Methods and systems for dynamic gene expression profiling |
| 12/29/2004 | EP1490486A2 Method of identifying genes controlling diferentiation |
| 12/29/2004 | EP1490110A2 Anti-alpha v beta 6 antibodies |
| 12/29/2004 | CA2529142A1 Rna interferases and methods of use thereof |
| 12/29/2004 | CA2527411A1 A method for the development of ruminant feed formulations |
| 12/29/2004 | CA2525379A1 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site |
| 12/23/2004 | WO2004111202A2 Neurotransmission-association proteins |
| 12/23/2004 | WO2004111201A2 Data classification using point-wise tests |
| 12/23/2004 | WO2004111200A2 Rtvp-glipr-like compositions and methods for the detection, treatment and prevention of prostate cancer |
| 12/23/2004 | WO2004111199A2 Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors |
| 12/23/2004 | WO2004111197A2 Gene expression signatures, methods and compositions for diagnosing disorders of the lung |
| 12/23/2004 | WO2004111195A2 Methods and use of zona-free therapeutic cloning |
| 12/23/2004 | WO2004111194A2 Method to increase protein production in culture |
| 12/23/2004 | WO2004111193A2 Prodrugs of mitotic kinesin inhibitors |
| 12/23/2004 | WO2004111192A2 Targeted delivery to legumain-expressing cells |
| 12/23/2004 | WO2004111191A2 Methods and compositions for controlling efficacy of rna silencing |
| 12/23/2004 | WO2004111190A2 IN VIVO HIGH THROUGHPUT SELECTION OF EFFECTIVE RNAi PROBES |
| 12/23/2004 | WO2004111188A2 Process for the treatment of chitinaceous materials and for the deacetylation of chitin |
| 12/23/2004 | WO2004111187A2 Methods for identification of coronaviruses |
| 12/23/2004 | WO2004111184A2 Method of amplifying metabolically inactive bacteria |
| 12/23/2004 | WO2004111183A2 Plant trichome-specific promoter and leucoplast signal sequence |
| 12/23/2004 | WO2004094673A8 Methods for monitoring drug activities in vivo |
| 12/23/2004 | WO2004083386A3 Methods of making repetitive sequences removed probes and use thereof |
| 12/23/2004 | WO2004083366A3 Methods utilizing novel target genes related to immune-mediated diseases |
| 12/23/2004 | WO2004081196A3 Formulations for cell- schedule dependent anticancer agents |
| 12/23/2004 | WO2004081185B1 Methods to enhance the activity of lignocellulose-degrading enzymes |
| 12/23/2004 | WO2004076623A3 Rna-interference for znfn3a1-gene as a method for inhibiting cancer cell growth |
| 12/23/2004 | WO2004072269A3 Bex4 nucleic acids, polypeptides, and method of using |
| 12/23/2004 | WO2004072263A3 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 12/23/2004 | WO2004072229A3 Chemical treatment of biological samples for nucleic acid extraction and kits therefor |
| 12/23/2004 | WO2004065550A3 Nucleic acid amplification using non-standard bases |
| 12/23/2004 | WO2004044122A3 Parallel or antiparallel, homologous or complementary binding of nucleic acids or analogues thereof to form duplex, triplex or quadruplex complexes |
| 12/23/2004 | WO2004016757A3 Methods, compositions and kits for producing nucleic and acid sequences |
| 12/23/2004 | WO2003097805A3 Delivery of nucleic acid-like compounds |
| 12/23/2004 | US20040261143 Targeted and regional cellular ablation in zebrafish |
| 12/23/2004 | US20040260073 Methods for purifying radiolabelled compounds |
| 12/23/2004 | US20040259248 RNA interference mediating small RNA molecules |
| 12/23/2004 | US20040259247 short interfering RNAs for use treating diseases, in protein separation or purification, in drug screening; cell with target gene-specific knockout phenotype; double stranded RNA; RNA fragments are the sequence-specific mediators of RNAi (RNA interference) |
| 12/23/2004 | US20040259177 Three dimensional cell cultures in a microscale fluid handling system |
| 12/23/2004 | US20040259162 container or multiwell plate for isolation of cellular components, such as polypeptides and nucleic acids, from host cells; interior surface comprising a sidewall formation and a bottom; a volume; a lytic reagent; and optionally a supported capture ligand |
| 12/23/2004 | US20040259133 precipitation ribonucleic acids by incubating with preservative in an aqueous solutions, then staining and analyzing the cells for messenger ribonucleic acid expression patterns by fluorescence in-situ hybridization |
| 12/23/2004 | US20040259127 Approaches to identifying genetic traits in animals |
| 12/23/2004 | US20040259125 Methods, systems and apparatus for identifying genetic differences in disease and drug response |
| 12/23/2004 | CA2536357A1 Targeted delivery to legumain-expressing cells |
| 12/23/2004 | CA2528418A1 Method to increase protein production in culture |